How much funding has MICROBIOTIX, INC. raised?

MICROBIOTIX, INC. has raised $37.2M in total funding, most recently a Series B round.

When was MICROBIOTIX, INC. founded?

MICROBIOTIX, INC. was founded in 2015.

Where is MICROBIOTIX, INC. headquartered?

MICROBIOTIX, INC. is headquartered in Worcester, Massachusetts, United States.

What industry is MICROBIOTIX, INC. in?

MICROBIOTIX, INC. operates in Biotech, Healthcare.

MICROBIOTIX, INC.

Microbiotix

Worcester, United States · Founded 2015 · $37.2M raised

Biotech

Healthcare

Headquarters: Worcester, Massachusetts
Founded: 2015
Business Model: B2B
Website: microbiotix.com

Total Funding: $37.2M
Last Round: $20.0M Series BSep 2025
Rounds: 3

About

Microbiotix is a clinical-stage biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting serious infectious diseases, including multi-drug resistant pathogens. Their lead compound MBX-400, a dual DNA polymerase/kinase inhibitor for human cytomegalovirus, has completed Phase 1 clinical testing. The company has consistently ranked among the top NIH SBIR award recipients among Massachusetts biotech companies.

Summary

MICROBIOTIX, INC. is a Biotech company based in Worcester, United States, founded in 2015. It has raised $37.2M in total across 3 rounds, most recently a $20.0M Series B round in Sep 2025.